Hemo Organic Limited (BOM:524590)

Hemo Organic Statistics

Total Valuation

Hemo Organic has a market cap or net worth of INR 50.36 million. The enterprise value is 66.76 million.

Market Cap	50.36M
Enterprise Value	66.76M

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Hemo Organic has 3.47 million shares outstanding. The number of shares has increased by 0.91% in one year.

Current Share Class	3.47M
Shares Outstanding	3.47M
Shares Change (YoY)	+0.91%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	42.69%
Owned by Institutions (%)	8.08%
Float	1.90M

Valuation Ratios

The trailing PE ratio is 39.11.

PE Ratio	39.11
Forward PE	n/a
PS Ratio	2.03
PB Ratio	-18.79
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	51.47
EV / Sales	2.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.46

Financial Position

The company has a current ratio of 1.26

Current Ratio	1.26
Quick Ratio	0.83
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-4.05
Interest Coverage	-476.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-0.94%
Return on Invested Capital (ROIC)	-2.68%
Return on Capital Employed (ROCE)	-3.47%
Revenue Per Employee	4.97M
Profits Per Employee	259,400
Employee Count	5
Asset Turnover	0.79
Inventory Turnover	n/a

Taxes

Income Tax	-1.77M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.04% in the last 52 weeks. The beta is -0.23, so Hemo Organic's price volatility has been lower than the market average.

Beta (5Y)	-0.23
52-Week Price Change	+17.04%
50-Day Moving Average	10.08
200-Day Moving Average	9.98
Relative Strength Index (RSI)	72.42
Average Volume (20 Days)	8,816

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hemo Organic had revenue of INR 24.86 million and earned 1.30 million in profits. Earnings per share was 0.37.

Revenue	24.86M
Gross Profit	2.85M
Operating Income	-476,000
Pretax Income	-477,000
Net Income	1.30M
EBITDA	n/a
EBIT	-476,000
Earnings Per Share (EPS)	0.37

Balance Sheet

The company has 5,000 in cash and 16.41 million in debt, giving a net cash position of -16.40 million or -4.73 per share.

Cash & Cash Equivalents	5,000
Total Debt	16.41M
Net Cash	-16.40M
Net Cash Per Share	-4.73
Equity (Book Value)	-2.68M
Book Value Per Share	-0.78
Working Capital	10.52M

Cash Flow

In the last 12 months, operating cash flow was -4.04 million and capital expenditures -15,000, giving a free cash flow of -4.06 million.

Operating Cash Flow	-4.04M
Capital Expenditures	-15,000
Free Cash Flow	-4.06M
FCF Per Share	-1.17

Margins

Gross margin is 11.47%, with operating and profit margins of -1.91% and 5.22%.

Gross Margin	11.47%
Operating Margin	-1.91%
Pretax Margin	-1.92%
Profit Margin	5.22%
EBITDA Margin	n/a
EBIT Margin	-1.91%
FCF Margin	n/a

Dividends & Yields

Hemo Organic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.91%
Shareholder Yield	-0.91%
Earnings Yield	2.58%
FCF Yield	-8.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hemo Organic has an Altman Z-Score of 0.08 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.08
Piotroski F-Score	2